What does that mean? Not much, except my days just got a lot less punny, and you might notice a different format to the newsletter in your inbox. Otherwise, expect the same great reporting and commentary.
A lot of the vaccines on that list either have important data that might come out this month or are launching critical trials to see how well they work.
By the end of the month, there's a possibility we'll know if at least one of the vaccines being tested is effective in preventing coronavirus infections.
On the treatment end of things, there's a chance to get some key data as well, especially for new antibody treatments.
When the pandemic hit, Dr. Ala Stanford was running a concierge medicine business with clients including Will Smith.
But when she saw how the pandemic was disproportionately impacting Black Americans, she set up a program to offer free testing in neighborhoods that were getting hit hard.
Kimberly Leonard has the scoop on how that program unfolded, and what's in store for Stanford's future.
It seems every time I close my computer or sign off for the weekend, another healthcare company files to go public!
Luckily, Megan Hernbroth was on last Friday night, when GoodRx, a company that helps patients get more affordable prescriptions via coupons, dropped its S-1.
Inside: she spotted details including that GoodRx is profitable (first time I've seen that in an S-1 since covering the digital health space!) and noted its top investor spots are filled by private equity firms and early employees.
Meanwhile, Megan has a rundown on Optum Ventures, the venture arm of healthcare giant UnitedHealth Group.
You've probably heard of UnitedHealth — it also operates the largest health insurer in the US, a massive pharmacy-benefits business, and more.
The investments give us a sense of UnitedHealth's views on the future of healthcare, and include everything from testing business LetsGetChecked to pharmacy startup Truepill.
Finally, my colleague Irene Jiang on the retail team here at Business Insider had an important story on how CVS is handling it when pharmacy staffers test positive for COVID-19.
A leaked email showed that a CVS district leader told pharmacy staff not to tell patients if a staffer who had tested positive for COVID-19 had filled their prescription.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.
Next Story
I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
A 13-year-old girl helped unearth an ancient Roman town. She's finally getting credit for it over 90 years later.
It's been a year since I graduated from college, and I still live at home. My therapist says I have post-graduation depression. 
RCB's Glenn Maxwell takes a "mental and physical" break from IPL 2024
IPL 2024: SRH vs RCB match rewrites history as both teams amass 549 runs in 240 balls
New X users will need to pay for posting: Elon Musk
Tech firms TCS, Accenture, Cognizant lead LinkedIn's top large companies list
Markets continue to slump on fears of escalating tensions in Middle East
